REDS — Redsense Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK82.84m
- SEK75.87m
- SEK24.97m
Annual income statement for Redsense Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 13.3 | 14.4 | 9.36 | 14.3 | 25 |
| Cost of Revenue | |||||
| Gross Profit | 7.93 | 9.96 | 10.4 | 11.3 | 13.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17.9 | 23.6 | 18 | 24.5 | 30 |
| Operating Profit | -4.59 | -9.15 | -8.67 | -10.2 | -5.04 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.07 | -9.03 | -7.97 | -8.76 | -4.51 |
| Net Income After Taxes | -5.07 | -9.03 | -7.97 | -8.76 | -4.51 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.07 | -9.03 | -7.97 | -8.76 | -4.51 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.07 | -9.03 | -7.97 | -8.76 | -4.51 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.42 | -0.57 | -0.804 | -0.624 | -0.321 |
| Dividends per Share |